首页 > 市场调查报告书 > 医疗设备

体外诊断

2030 年亚太地区凝血市场预测 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户

市场调查报告书

商品编码

1494294

2030 年亚太地区凝血市场预测 - 区域分析 - 按疾病适应症、类型、产品、技术和最终用户

Asia Pacific Coagulation Market Forecast to 2030 - Regional Analysis - by Disease Indications, Type, Offering, Technology, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 113 Pages | 订单完成后即时交付

价格

简介目录图表

2022年亚太地区凝血市场估值为8.8952亿美元，预计2030年将达16.7249亿美元；预计2022年至2030年复合年增长率为8.2%。

主要市场参与者不断发展的有机和无机策略推动亚太混凝市场

生活习惯的改变和老年人口的增加是增加血液疾病盛行率的主要因素。因此，早期诊断和治疗的需求日益增长。主要参与者正在透过各种有机和无机策略采取多项倡议，以提高患者群体的生活品质。

2020年7月，希森美康公司在日本推出自动凝血分析仪CN-6500/CN-3500。此分析仪可测量凝血和血小板聚集参数，以及血栓形成和止血参数。
2021 年 10 月，Trivitron Healthcare 推出了由印度 Diagon Ltd 製造的新系列凝血分析仪产品。
2021 年 6 月，Trivitron Healthcare 推出了 NANO H5 和 NANO H110，有助于监测糖尿病、血红素变异和地中海贫血。
2021 年 2 月，西门子医疗与希森美康公司续签了全球供应、分销、销售和服务止血产品的协议。该协议还包括延期多年。此外，西门子 Healthineers 也同意分销 Sysmex 的自动凝血分析仪，例如 CN-3000 和 CN-6000。
2022年7月，HORIBA Medical推出了最新的Yumizen G800和G1550止血分析仪，以及一系列用于常见凝血的便捷即用型试剂产品。随着产品线的扩展，HORIBA Medical 现在为各种规模和要求的实验室提供全面的止血系统和先进试剂选择。

因此，主要市场参与者采用各种有机和无机策略预计将为预测期内混凝市场的成长提供机会。

亚太地区凝血市场概况

亚太地区凝血市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。促进该地区市场进步的因素包括老年人口的增加、心血管疾病发病率的增加、出血性疾病盛行率的增加、分销网络的发展以及凝血分析仪的进步。

根据国家生物技术资讯中心（NCBI）发表的《2022年中国心血管健康与疾病》文章，心血管疾病（CVD）分别占农村和城市地区约47%和约44%的死亡原因分别在中国。 2020年，预计中国将有近3.3亿患者患有心血管疾病。根据《柳叶刀》发表的一项研究，心血管疾病每年在中国导致约 400 万人死亡。 CVD患者体内的凝血因子浓度升高。因此，心血管疾病盛行率的激增正在推动中国凝血市场的成长。

亚太地区凝血市场收入及 2030 年预测（百万美元）

亚太地区凝血市场细分

亚太地区凝血市场根据疾病适应症、类型、产品、技术、最终用户和国家进行细分。

根据疾病适应症，亚太地区凝血市场分为维生素 K 缺乏症、肝病、瀰漫性血管内凝血及肺栓塞、循环抗凝血剂的发展、血友病、冯维勒布兰德氏症等。 2022 年，肝病领域占据亚太地区最大的凝血市场。

根据类型，亚太凝血市场分为临床实验室分析仪和即时检测分析仪。 2022 年，临床实验室分析仪细分市场将在亚太地区凝血市场中占据更大份额。凝血因子等。

在产品方面，亚太地区凝血市场分为诊断和治疗。至2022年，诊断细分市场将占据更大的亚太凝血市场份额。 D-二聚体测试、血小板功能测试等。治疗部分进一步细分为抗纤溶药物、避孕药、去氨加压素和免疫抑制药物、维生素K 补充剂、血液稀释剂、凝血酶抑制剂或血栓溶解剂、替代疗法、导管辅助血栓清除等。

依技术划分，亚太凝固市场分为光学技术、机械技术、电化学技术等。 2022 年，光学技术领域占据亚太地区最大的凝血市场。

依最终用户划分，亚太地区凝血市场分为临床实验室、医院等。 2022 年，医院细分市场占据亚太地区最大的凝血市场。

依国家划分，亚太地区凝血市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。 2022年，中国在亚太地区凝血市场占据主导地位。

F.霍夫曼-拉罗氏有限公司；根瑞生物科技有限公司；堀场有限公司； ImproGen Diagnostik Kimya San & Tic Ltd.Sti.、Siemens Healthineers AG；希森美康公司；和 Transasia Bio-Medicals Ltd 是亚太凝血市场上的一些领先公司。

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.
In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.
In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Asia Pacific Coagulation Market Overview

The Asia Pacific coagulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising geriatric population, increasing incidences of cardiovascular diseases, growing prevalence of bleeding disorders, development of distribution networks, and advancements in coagulation analyzers.

According to an article published in the National Center for Biotechnology Information (NCBI), "Cardiovascular Health and Diseases in China 2022," cardiovascular diseases (CVD) are the cause of ~47% and ~44% of all deaths in rural and urban regions in China, respectively. In 2020, nearly 330 million patients are predicted to suffer from CVD in China. According to a research study published in The Lancet, CVDs cause ~4 million deaths each year in China. CVD patients have elevated levels of coagulation factors in their bodies. Hence, an upsurge in the prevalence of CVDs is fueling the growth of the coagulation market in China.

Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Coagulation Market Segmentation

The Asia Pacific coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Asia Pacific coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Asia Pacific coagulation market share in 2022.

Based on type, the Asia Pacific coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Asia Pacific coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Asia Pacific coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Asia Pacific coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Asia Pacific coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Asia Pacific coagulation market share in 2022.

By end user, the Asia Pacific coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Asia Pacific coagulation market share in 2022.

Based on country, the Asia Pacific coagulation market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Sti., Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the Asia Pacific coagulation market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of Blood Disorders
- 4.1.2 Rising Prevalence of Cardiovascular Diseases
4.2 Market Restraints
- 4.2.1 High Costs Associated with Coagulation Analyzers
4.3 Market Opportunities
- 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
4.4 Future Trends
- 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
4.5 Impact Analysis

5. Coagulation Market - Asia Pacific Market Analysis

5.1 Asia Pacific Coagulation Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview
6.2 Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
6.3 Vitamin K Deficiency
- 6.3.1 Overview
- 6.3.2 Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Liver Disease
- 6.4.1 Overview
- 6.4.2 Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 6.5.1 Overview
- 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Development of Circulating Anticoagulant
- 6.6.1 Overview
- 6.6.2 Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Hemophilia
- 6.7.1 Overview
- 6.7.2 Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Von Willebrand's Disease
- 6.8.1 Overview
- 6.8.2 Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Others
- 6.9.1 Overview
- 6.9.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Clinical Laboratory Analyzers
- 7.3.1 Overview
- 7.3.2 Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzers
7.4 Point-of-Care Testing Analyzers
- 7.4.1 Overview
- 7.4.2 Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview
8.2 Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
8.3 Diagnosis
- 8.3.1 Overview
- 8.3.2 Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Asia Pacific Coagulation Market, by Diagnosis
8.4 Treatment
- 8.4.1 Overview
- 8.4.2 Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Asia Pacific Coagulation Market, by Treatment

9. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview
9.2 Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
9.3 Optical Technology
- 9.3.1 Overview
- 9.3.2 Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Mechanical Technology
- 9.4.1 Overview
- 9.4.2 Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Electrochemical Technology
- 9.5.1 Overview
- 9.5.2 Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals
- 10.4.1 Overview
- 10.4.2 Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Coagulation Market - Country Analysis

11.1 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
- 11.1.1 Asia Pacific Coagulation Market by Country
  - 11.1.1.1 China
    - 11.1.1.1.1 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.1.2 China Coagulation Market, by Disease Indication
    - 11.1.1.1.3 China Coagulation Market, by Type
    - 11.1.1.1.3.1 China Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.1.4 China Coagulation Market, by Offering
    - 11.1.1.1.4.1 China Coagulation Market, by Diagnosis
    - 11.1.1.1.4.2 China Coagulation Market, by Treatment
    - 11.1.1.1.5 China Coagulation Market, by Technology
    - 11.1.1.1.6 China Coagulation Market, by End User
  - 11.1.1.2 Japan
    - 11.1.1.2.1 Overview
    - 11.1.1.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.2.3 Japan Coagulation Market, by Disease Indication
    - 11.1.1.2.4 Japan Coagulation Market, by Type
    - 11.1.1.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.2.5 Japan Coagulation Market, by Offering
    - 11.1.1.2.5.1 Japan Coagulation Market, by Diagnosis
    - 11.1.1.2.5.2 Japan Coagulation Market, by Treatment
    - 11.1.1.2.6 Japan Coagulation Market, by Technology
    - 11.1.1.2.7 Japan Coagulation Market, by End User
  - 11.1.1.3 India
    - 11.1.1.3.1 Overview
    - 11.1.1.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.3.3 India Coagulation Market, by Disease Indication
    - 11.1.1.3.4 India Coagulation Market, by Type
    - 11.1.1.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.3.5 India Coagulation Market, by Offering
    - 11.1.1.3.5.1 India Coagulation Market, by Diagnosis
    - 11.1.1.3.5.2 India Coagulation Market, by Treatment
    - 11.1.1.3.6 India Coagulation Market, by Technology
    - 11.1.1.3.7 India Coagulation Market, by End User
  - 11.1.1.4 Australia
    - 11.1.1.4.1 Overview
    - 11.1.1.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.4.3 Australia Coagulation Market, by Disease Indication
    - 11.1.1.4.4 Australia Coagulation Market, by Type
    - 11.1.1.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.4.5 Australia Coagulation Market, by Offering
    - 11.1.1.4.5.1 Australia Coagulation Market, by Diagnosis
    - 11.1.1.4.5.2 Australia Coagulation Market, by Treatment
    - 11.1.1.4.6 Australia Coagulation Market, by Technology
    - 11.1.1.4.7 Australia Coagulation Market, by End User
  - 11.1.1.5 South Korea
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.5.3 South Korea Coagulation Market, by Disease Indication
    - 11.1.1.5.4 South Korea Coagulation Market, by Type
    - 11.1.1.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.5.5 South Korea Coagulation Market, by Offering
    - 11.1.1.5.5.1 South Korea Coagulation Market, by Diagnosis
    - 11.1.1.5.5.2 South Korea Coagulation Market, by Treatment
    - 11.1.1.5.6 South Korea Coagulation Market, by Technology
    - 11.1.1.5.7 South Korea Coagulation Market, by End User
  - 11.1.1.6 Rest of Asia Pacific
    - 11.1.1.6.1 Overview
    - 11.1.1.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 11.1.1.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
    - 11.1.1.6.4 Rest of Asia Pacific Coagulation Market, by Type
    - 11.1.1.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
    - 11.1.1.6.5 Rest of Asia Pacific Coagulation Market, by Offering
    - 11.1.1.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
    - 11.1.1.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
    - 11.1.1.6.6 Rest of Asia Pacific Coagulation Market, by Technology
    - 11.1.1.6.7 Rest of Asia Pacific Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Coagulation Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Sysmex Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Genrui Biotech Co., Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Transasia Bio-Medicals Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Horiba Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Asia Pacific Coagulation Market Segmentation
Table 2. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 4. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 8. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 9. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 10. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 11. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 12. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 13. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 14. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 15. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 16. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 17. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 18. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 19. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 20. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 21. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 22. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 23. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 24. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 25. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 26. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 27. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 28. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 29. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 30. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 31. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 32. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 34. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 35. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 36. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 37. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 38. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 39. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 40. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 41. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 42. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 43. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 44. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 45. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 46. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 47. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 48. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 49. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 50. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 51. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 52. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 54. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 55. Recent Inorganic Growth Strategies in the Coagulation Market
Table 56. Recent Organic Growth Strategies in the Coagulation Market
Table 57. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Asia Pacific Coagulation Market Segmentation, By Country
Figure 2. Asia Pacific Coagulation Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 5. Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 6. Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 14. Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 17. Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 20. Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 25. Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Coagulation Market, By Geography, 2022 (US$ Million)
Figure 29. Asia Pacific Coagulation Market, By Key Countries, 2022 and 2030 (%)
Figure 30. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 31. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 32. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 33. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 34. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 35. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 36. Growth Strategies in the Coagulation Market